FDA Safe Use Initiative Targets NSAIDs, Pediatric Dosing, Drug-Impaired Driving
This article was originally published in The Tan Sheet
CDER touts its Safe Use Initiative as addressing OTC and Rx mis-use and reducing risks to consumers by partnering with industry stakeholders and health care professionals. CDER Professional Affairs and Stakeholder Engagement Director John Whyte says he wants to “build capacity” behind the program.
You may also be interested in...
FDA suggests new and repeats previous recommendations to reduce the risk of pediatric overdose with acetaminophen products due either to unsupervised ingestion or therapeutic errors. The guidance includes greater detail on delivery devices and labeling information for pediatric acetaminophen OTCs.
John Whyte joins FDA from Discovery Channel to be director of professional affairs and stakeholder engagement.
ELC’s Guillaume Jesel has been named president of global brands overseeing Tom Ford Beauty and Balmain Beauty, the latter targeted for launch in fall 2024 under a licensing agreement with the French fashion house announced on 26 September. Jesel also will head up luxury business development with a “key role in prospective acquisitions and investment strategy.”